ClinVar Miner

Submissions for variant NM_001243279.3(ACSF3):c.1536G>A (p.Trp512Ter)

gnomAD frequency: 0.00001  dbSNP: rs1025201214
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV001330534 SCV001522242 likely pathogenic Combined malonic and methylmalonic acidemia 2020-02-26 criteria provided, single submitter clinical testing This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001330534 SCV003922443 likely pathogenic Combined malonic and methylmalonic acidemia 2023-03-03 criteria provided, single submitter clinical testing Variant summary: ACSF3 c.1536G>A (p.Trp512X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in association with Malonic & methylmalonic aciduria in HGMD. The variant was absent in 251470 control chromosomes. To our knowledge, no occurrence of c.1536G>A in individuals affected with Combined Malonic And Methylmalonic Aciduria and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV001330534 SCV004518688 pathogenic Combined malonic and methylmalonic acidemia 2024-01-11 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Trp512*) in the ACSF3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACSF3 are known to be pathogenic (PMID: 21841779, 26827111). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with ACSF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1029290). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.